Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.
- 1 May 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 4 (3), 431-437
- https://doi.org/10.1161/01.hyp.4.3.431
Abstract
The influence of dopamine on plasma catecholamine, prolactin (PRL), and mean arterial pressure (MAP) responses to upright posture and isometric handgrip exercise and the recumbent circadian PRL and MAP patterns in essential hypertension were examined. Nine men with sustained essential hypertension and 9 age- and weight-matched normotensive controls were studied after they had reached metabolic equilibrium on a constant intake of 100 meq Na and 80 meq K. The hypertensive group, but not the normotensive group, displayed a PRL response to upright posture and isometric handgrip. Hypertensives and normotensives had similar basal supine catecholamine levels and similar epinephrine and dopamine responses to posture and handgrip. The hypertensives had greater (P < 0.01) norepinephrine (NE) responses to posture and handgrip than did the normotensives. Bromocriptine (BEC) depressed supine basal MAP in the hypertensives but not in the normotensives. BEC markedly decreased the basal PRL levels in both groups. BEC eliminated the PRL response to posture in the hypertensives and depressed the NE response to posture and handgrip to a greater extent (P < 0.01) in the hypertensives than in the normotensives. In the control period, a clear circadian rhythm of PRL and MAP was noted in both groups. In both groups an increase in PRL concentration occurred between 60 to 90 min after sleep onset, and was followed by several larger secretory episodes resulting in progressively higher levels during the night with peak values occurring at the end of the sleep period, generally at 0500 to 0600 h. During the hour after awakening, a fall in PRL concentration began, and lowest levels were reached at approximately 1100 h in both groups. The mean 24-h PRL levels in the hypertensive group (12.6 .+-. 0.5 ng/ml) were higher (P < 0.01) than in the normotensives (10.8 .+-. 0.4 ng/ml). During the waking hours, there was a correlation (r = 0.57, P < 0.01) between recumbent PRL levels and MAP. BEC therapy lowered MAP levels throughout the 24 h in the hypertensive group. BEC also eliminated the circadian rhythm of PRL secretion. Thus, circadian variations in PRL secretion and blood pressure appear to be modulated by a central and/or peripheral dopaminergic mechanism. Decreased dopaminergic activity in essential hypertension may account, in part, for aberrances in PRL secretion and elevated blood pressure in this disease state.This publication has 40 references indexed in Scilit:
- Effects of bromocriptine on responses to stress in spontaneously hypertensive rats.Hypertension, 1981
- Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension.Hypertension, 1980
- Catecholamines and pituitary prolactin releaseReproduction, 1980
- Is Normoreninemic Essential Hypertension Caused by Disordered Central Dopaminergic Regulation?Clinical and Experimental Hypertension, 1980
- Bromocriptine is a potent α-adrenoceptor antagonist in the perfused mesenteric blood vessels of the ratJournal of Pharmacy and Pharmacology, 1978
- SALURETIC ACTION OF ALDOSTERONE IN THE PRESENCE OF INCREASED SALT INTAKE AND RESTORATION OF NORMAL ACTION BY PROLACTIN OR BY OXYTOCINJournal of Endocrinology, 1972
- ACTIONS OF PROLACTIN ON HUMAN RENAL FUNCTIONThe Lancet, 1971
- Cardiovascular and Respiratory Changes During Sleep in Normal and Hypertensive SubjectsCardiovascular Research, 1969
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955